Cationic Lipid Compound and Composition for Delivery of Nucleic Acids and Use Thereof
US-2024360072-A1 · Oct 31, 2024 · US
BCL-3 inhibitors
US10273218B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10273218-B2 |
| Application number | US-201515500016-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 31, 2015 |
| Priority date | Jul 31, 2014 |
| Publication date | Apr 30, 2019 |
| Grant date | Apr 30, 2019 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present application relates to compounds of any one of Formulae I, Ia, Ib, Ic, Id, Ie, and If. Compounds of Formula (I) have the structure: wherein A, B, W, Y, Z, R 2 , R 4 , R 5 , R 6 , R q and q are as defined herein. The compounds can be used as inhibitors of Bcl-3 and can be used for the treatment of cancer, particularly metastatic cancer.
First claim
Opening claim text (preview).
The invention claimed is: 1. A compound of the following structure: or a pharmaceutically acceptable salt thereof. 2. A pharmaceutical composition comprising the compound according to claim 1 and a pharmaceutically or veterinarily acceptable excipient or carrier.
Assignees
Inventors
Classifications
specific for leukemia · CPC title
Antineoplastic agents · CPC title
Amides; Imides · CPC title
having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated · CPC title
having no double bonds between ring members or between ring members and non-ring members · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US10273218B2 cover?
- The present application relates to compounds of any one of Formulae I, Ia, Ib, Ic, Id, Ie, and If. Compounds of Formula (I) have the structure: wherein A, B, W, Y, Z, R 2 , R 4 , R 5 , R 6 , R q and q are as defined herein. The compounds can be used as inhibitors of Bcl…
- Who is the assignee on this patent?
- Univ College Cardiff Consultants Ltd
- What technology area does this patent fall under?
- Primary CPC classification C07D295/13. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Apr 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).